Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer.
Journal: The New England journal of medicine
Published: May 06, 2026
Understanding the Promise and Challenges of Tumor-Agnostic Therapy: Could One Size Really Fit All?
Journal: Cancers
Published: April 11, 2026
Quiescent tumor cells shape the immunosuppressive microenvironment in pancreatic cancer.
Journal: Nature communications
Published: March 06, 2026
ctDNA in Pancreatic Adenocarcinoma: A Critical Appraisal.
Journal: Current oncology (Toronto, Ont.)
Published: August 24, 2025
Measuring the Unseen Burden: Immunotherapy and Targeted Therapy Reduce Treatment-Related Time Toxicity in Incurable Malignancies.
Journal: World journal of oncology
Published: July 06, 2025
Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trial.
Journal: Nature communications
Published: November 20, 2024
The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancer.
Journal: NPJ precision oncology
Published: August 04, 2024
Impact of an Inter-Professional Clinic on Pancreatic Cancer Outcomes: A Retrospective Cohort Study.
Journal: Current oncology (Toronto, Ont.)
Published: April 04, 2024
A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinoma.
Journal: Journal of gastrointestinal oncology
Published: January 25, 2022
Primary ambulatory thromboprophylaxis in patients with pancreatic cancer receiving chemotherapy: hope or hype?
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: October 19, 2021
Phase II Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Metastatic Colorectal Cancer.
Journal: Clinical colorectal cancer
Published: May 24, 2021
Last Updated: 09/26/2026